Click for best price
HGH Biosimilars Market Size, Share 2023
The global HGH Biosimilars market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
HGH Biosimilars is DNA recombinant human growth hormone, which has the same function as human growth hormone. It can promote bone, visceral and whole body growth, promote protein synthesis, affect fat and mineral metabolism, and play a key role in human growth and development. Subcutaneous injection of about 80% was absorbed, 5 hours to reach the peak of blood drug concentration, the half-life of 4 hours. About 90% of the injection dose is metabolized in the liver. Only about 0.1% of the dose is excreted from the biliary tract and the kidneys.
This report aims to provide a comprehensive presentation of the global market for HGH Biosimilars, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HGH Biosimilars. This report contains market size and forecasts of HGH Biosimilars in global, including the following market information:
- Global HGH Biosimilars Market Revenue, 2018-2023, 2024-2029, ($ millions)
- Global HGH Biosimilars Market Sales, 2018-2023, 2024-2029, (K Units)
- Global top five HGH Biosimilars companies in 2022 (%)
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for HGH Biosimilars in US$ by following Product Segments.: Clinical, Experiment and Others
Company profiles are primarily based on public domain information including company
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm
We surveyed the HGH Biosimilars manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global HGH Biosimilars Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global HGH Biosimilars Market Segment Percentages, by Type, 2022 (%)
Global HGH Biosimilars Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global HGH Biosimilars Market Segment Percentages, by Application, 2022 (%)
Global HGH Biosimilars Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global HGH Biosimilars Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies HGH Biosimilars revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies HGH Biosimilars revenues share in global market, 2022 (%)
Key companies HGH Biosimilars sales in global market, 2018-2023 (Estimated), (K Units)
Key companies HGH Biosimilars sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Johnson & Johnson
- Gilead Sciences
- Pacira
- Sun Pharmaceutical
- Luye Pharma
- Sigma-Tau Group
- Fudan-Zhangjiang
- Teva Pharmaceutical
- CSPC
- Novartis
- Kingond Pharm
Outline of Major Chapters:
- Chapter 1: Introduces the definition of HGH Biosimilars, market overview.
- Chapter 2: Global HGH Biosimilars market size in revenue and volume.
- Chapter 3: Detailed analysis of HGH Biosimilars manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of HGH Biosimilars in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: Global HGH Biosimilars capacity by region & country.
- Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
- Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
- Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
HGH Biosimilars Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
79 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 HGH Biosimilars Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global HGH Biosimilars Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global HGH Biosimilars Overall Market Size
2.1 Global HGH Biosimilars Market Size: 2022 VS 2029
2.2 Global HGH Biosimilars Revenue, Prospects & Forecasts: 2018-2029
2.3 Global HGH Biosimilars Sales: 2018-2029
3 Company Landscape
3.1 Top HGH Biosimilars Players in Global Market
3.2 Top Global HGH Biosimilars Companies Ranked by Revenue
3.3 Global HGH Biosimilars Revenue by Companies
3.4 Global HGH Biosimilars Sales by Companies
3.5 Global HGH Biosimilars Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 HGH Biosimilars Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers HGH Biosimilars Product Type
3.8 Tier 1, Tier 2 and Tier 3 HGH Biosimilars Players in Global Market
3.8.1 List of Global Tier 1 HGH Biosimilars Companies
3.8.2 List of Global Tier 2 and Tier 3 HGH Biosimilars Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global HGH Biosimilars Market Size Markets, 2022 & 2029
4.1.2 Clinical
4.1.3 Experiment
4.2 By Type - Global HGH Biosimilars Revenue & Forecasts
4.2.1 By Type - Global HGH Biosimilars Revenue, 2018-2023
4.2.2 By Type - Global HGH Biosimilars Revenue, 2024-2029
4.2.3 By Type - Global HGH Biosimilars Revenue Market Share, 2018-2029
4.3 By Type - Global HGH Biosimilars Sales & Forecasts
4.3.1 By Type - Global HGH Biosimilars Sales, 2018-2023
4.3.2 By Type - Global HGH Biosimilars Sales, 2024-2029
4.3.3 By Type - Global HGH Biosimilars Sales Market Share, 2018-2029
4.4 By Type - Global HGH Biosimilars Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global HGH Biosimilars Market Size, 2022 & 2029
5.1.2 Treament
5.1.3 Prevention
5.2 By Application - Global HGH Biosimilars Revenue & Forecasts
5.2.1 By Application - Global HGH Biosimilars Revenue, 2018-2023
5.2.2 By Application - Global HGH Biosimilars Revenue, 2024-2029
5.2.3 By Application - Global HGH Biosimilars Revenue Market Share, 2018-2029
5.3 By Application - Global HGH Biosimilars Sales & Forecasts
5.3.1 By Application - Global HGH Biosimilars Sales, 2018-2023
5.3.2 By Application - Global HGH Biosimilars Sales, 2024-2029
5.3.3 By Application - Global HGH Biosimilars Sales Market Share, 2018-2029
5.4 By Application - Global HGH Biosimilars Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global HGH Biosimilars Market Size, 2022 & 2029
6.2 By Region - Global HGH Biosimilars Revenue & Forecasts
6.2.1 By Region - Global HGH Biosimilars Revenue, 2018-2023
6.2.2 By Region - Global HGH Biosimilars Revenue, 2024-2029
6.2.3 By Region - Global HGH Biosimilars Revenue Market Share, 2018-2029
6.3 By Region - Global HGH Biosimilars Sales & Forecasts
6.3.1 By Region - Global HGH Biosimilars Sales, 2018-2023
6.3.2 By Region - Global HGH Biosimilars Sales, 2024-2029
6.3.3 By Region - Global HGH Biosimilars Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America HGH Biosimilars Revenue, 2018-2029
6.4.2 By Country - North America HGH Biosimilars Sales, 2018-2029
6.4.3 US HGH Biosimilars Market Size, 2018-2029
6.4.4 Canada HGH Biosimilars Market Size, 2018-2029
6.4.5 Mexico HGH Biosimilars Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe HGH Biosimilars Revenue, 2018-2029
6.5.2 By Country - Europe HGH Biosimilars Sales, 2018-2029
6.5.3 Germany HGH Biosimilars Market Size, 2018-2029
6.5.4 France HGH Biosimilars Market Size, 2018-2029
6.5.5 U.K. HGH Biosimilars Market Size, 2018-2029
6.5.6 Italy HGH Biosimilars Market Size, 2018-2029
6.5.7 Russia HGH Biosimilars Market Size, 2018-2029
6.5.8 Nordic Countries HGH Biosimilars Market Size, 2018-2029
6.5.9 Benelux HGH Biosimilars Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia HGH Biosimilars Revenue, 2018-2029
6.6.2 By Region - Asia HGH Biosimilars Sales, 2018-2029
6.6.3 China HGH Biosimilars Market Size, 2018-2029
6.6.4 Japan HGH Biosimilars Market Size, 2018-2029
6.6.5 South Korea HGH Biosimilars Market Size, 2018-2029
6.6.6 Southeast Asia HGH Biosimilars Market Size, 2018-2029
6.6.7 India HGH Biosimilars Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America HGH Biosimilars Revenue, 2018-2029
6.7.2 By Country - South America HGH Biosimilars Sales, 2018-2029
6.7.3 Brazil HGH Biosimilars Market Size, 2018-2029
6.7.4 Argentina HGH Biosimilars Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa HGH Biosimilars Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa HGH Biosimilars Sales, 2018-2029
6.8.3 Turkey HGH Biosimilars Market Size, 2018-2029
6.8.4 Israel HGH Biosimilars Market Size, 2018-2029
6.8.5 Saudi Arabia HGH Biosimilars Market Size, 2018-2029
6.8.6 UAE HGH Biosimilars Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson HGH Biosimilars Major Product Offerings
7.1.4 Johnson & Johnson HGH Biosimilars Sales and Revenue in Global (2018-2023)
7.1.5 Johnson & Johnson Key News & Latest Developments
7.2 Gilead Sciences
7.2.1 Gilead Sciences Company Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences HGH Biosimilars Major Product Offerings
7.2.4 Gilead Sciences HGH Biosimilars Sales and Revenue in Global (2018-2023)
7.2.5 Gilead Sciences Key News & Latest Developments
7.3 Pacira
7.3.1 Pacira Company Summary
7.3.2 Pacira Business Overview
7.3.3 Pacira HGH Biosimilars Major Product Offerings
7.3.4 Pacira HGH Biosimilars Sales and Revenue in Global (2018-2023)
7.3.5 Pacira Key News & Latest Developments
7.4 Sun Pharmaceutical
7.4.1 Sun Pharmaceutical Company Summary
7.4.2 Sun Pharmaceutical Business Overview
7.4.3 Sun Pharmaceutical HGH Biosimilars Major Product Offerings
7.4.4 Sun Pharmaceutical HGH Biosimilars Sales and Revenue in Global (2018-2023)
7.4.5 Sun Pharmaceutical Key News & Latest Developments
7.5 Luye Pharma
7.5.1 Luye Pharma Company Summary
7.5.2 Luye Pharma Business Overview
7.5.3 Luye Pharma HGH Biosimilars Major Product Offerings
7.5.4 Luye Pharma HGH Biosimilars Sales and Revenue in Global (2018-2023)
7.5.5 Luye Pharma Key News & Latest Developments
7.6 Sigma-Tau Group
7.6.1 Sigma-Tau Group Company Summary
7.6.2 Sigma-Tau Group Business Overview
7.6.3 Sigma-Tau Group HGH Biosimilars Major Product Offerings
7.6.4 Sigma-Tau Group HGH Biosimilars Sales and Revenue in Global (2018-2023)
7.6.5 Sigma-Tau Group Key News & Latest Developments
7.7 Fudan-Zhangjiang
7.7.1 Fudan-Zhangjiang Company Summary
7.7.2 Fudan-Zhangjiang Business Overview
7.7.3 Fudan-Zhangjiang HGH Biosimilars Major Product Offerings
7.7.4 Fudan-Zhangjiang HGH Biosimilars Sales and Revenue in Global (2018-2023)
7.7.5 Fudan-Zhangjiang Key News & Latest Developments
7.8 Teva Pharmaceutical
7.8.1 Teva Pharmaceutical Company Summary
7.8.2 Teva Pharmaceutical Business Overview
7.8.3 Teva Pharmaceutical HGH Biosimilars Major Product Offerings
7.8.4 Teva Pharmaceutical HGH Biosimilars Sales and Revenue in Global (2018-2023)
7.8.5 Teva Pharmaceutical Key News & Latest Developments
7.9 CSPC
7.9.1 CSPC Company Summary
7.9.2 CSPC Business Overview
7.9.3 CSPC HGH Biosimilars Major Product Offerings
7.9.4 CSPC HGH Biosimilars Sales and Revenue in Global (2018-2023)
7.9.5 CSPC Key News & Latest Developments
7.10 Novartis
7.10.1 Novartis Company Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis HGH Biosimilars Major Product Offerings
7.10.4 Novartis HGH Biosimilars Sales and Revenue in Global (2018-2023)
7.10.5 Novartis Key News & Latest Developments
7.11 Kingond Pharm
7.11.1 Kingond Pharm Company Summary
7.11.2 Kingond Pharm HGH Biosimilars Business Overview
7.11.3 Kingond Pharm HGH Biosimilars Major Product Offerings
7.11.4 Kingond Pharm HGH Biosimilars Sales and Revenue in Global (2018-2023)
7.11.5 Kingond Pharm Key News & Latest Developments
8 Global HGH Biosimilars Production Capacity, Analysis
8.1 Global HGH Biosimilars Production Capacity, 2018-2029
8.2 HGH Biosimilars Production Capacity of Key Manufacturers in Global Market
8.3 Global HGH Biosimilars Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 HGH Biosimilars Supply Chain Analysis
10.1 HGH Biosimilars Industry Value Chain
10.2 HGH Biosimilars Upstream Market
10.3 HGH Biosimilars Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 HGH Biosimilars Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of HGH Biosimilars in Global Market
Table 2. Top HGH Biosimilars Players in Global Market, Ranking by Revenue (2022)
Table 3. Global HGH Biosimilars Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global HGH Biosimilars Revenue Share by Companies, 2018-2023
Table 5. Global HGH Biosimilars Sales by Companies, (K Units), 2018-2023
Table 6. Global HGH Biosimilars Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers HGH Biosimilars Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers HGH Biosimilars Product Type
Table 9. List of Global Tier 1 HGH Biosimilars Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 HGH Biosimilars Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global HGH Biosimilars Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global HGH Biosimilars Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global HGH Biosimilars Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global HGH Biosimilars Sales (K Units), 2018-2023
Table 15. By Type - Global HGH Biosimilars Sales (K Units), 2024-2029
Table 16. By Application ? Global HGH Biosimilars Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global HGH Biosimilars Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global HGH Biosimilars Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global HGH Biosimilars Sales (K Units), 2018-2023
Table 20. By Application - Global HGH Biosimilars Sales (K Units), 2024-2029
Table 21. By Region ? Global HGH Biosimilars Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global HGH Biosimilars Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global HGH Biosimilars Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global HGH Biosimilars Sales (K Units), 2018-2023
Table 25. By Region - Global HGH Biosimilars Sales (K Units), 2024-2029
Table 26. By Country - North America HGH Biosimilars Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America HGH Biosimilars Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America HGH Biosimilars Sales, (K Units), 2018-2023
Table 29. By Country - North America HGH Biosimilars Sales, (K Units), 2024-2029
Table 30. By Country - Europe HGH Biosimilars Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe HGH Biosimilars Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe HGH Biosimilars Sales, (K Units), 2018-2023
Table 33. By Country - Europe HGH Biosimilars Sales, (K Units), 2024-2029
Table 34. By Region - Asia HGH Biosimilars Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia HGH Biosimilars Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia HGH Biosimilars Sales, (K Units), 2018-2023
Table 37. By Region - Asia HGH Biosimilars Sales, (K Units), 2024-2029
Table 38. By Country - South America HGH Biosimilars Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America HGH Biosimilars Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America HGH Biosimilars Sales, (K Units), 2018-2023
Table 41. By Country - South America HGH Biosimilars Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa HGH Biosimilars Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa HGH Biosimilars Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa HGH Biosimilars Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa HGH Biosimilars Sales, (K Units), 2024-2029
Table 46. Johnson & Johnson Company Summary
Table 47. Johnson & Johnson HGH Biosimilars Product Offerings
Table 48. Johnson & Johnson HGH Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Johnson & Johnson Key News & Latest Developments
Table 50. Gilead Sciences Company Summary
Table 51. Gilead Sciences HGH Biosimilars Product Offerings
Table 52. Gilead Sciences HGH Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Gilead Sciences Key News & Latest Developments
Table 54. Pacira Company Summary
Table 55. Pacira HGH Biosimilars Product Offerings
Table 56. Pacira HGH Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Pacira Key News & Latest Developments
Table 58. Sun Pharmaceutical Company Summary
Table 59. Sun Pharmaceutical HGH Biosimilars Product Offerings
Table 60. Sun Pharmaceutical HGH Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Sun Pharmaceutical Key News & Latest Developments
Table 62. Luye Pharma Company Summary
Table 63. Luye Pharma HGH Biosimilars Product Offerings
Table 64. Luye Pharma HGH Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Luye Pharma Key News & Latest Developments
Table 66. Sigma-Tau Group Company Summary
Table 67. Sigma-Tau Group HGH Biosimilars Product Offerings
Table 68. Sigma-Tau Group HGH Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Sigma-Tau Group Key News & Latest Developments
Table 70. Fudan-Zhangjiang Company Summary
Table 71. Fudan-Zhangjiang HGH Biosimilars Product Offerings
Table 72. Fudan-Zhangjiang HGH Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Fudan-Zhangjiang Key News & Latest Developments
Table 74. Teva Pharmaceutical Company Summary
Table 75. Teva Pharmaceutical HGH Biosimilars Product Offerings
Table 76. Teva Pharmaceutical HGH Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Teva Pharmaceutical Key News & Latest Developments
Table 78. CSPC Company Summary
Table 79. CSPC HGH Biosimilars Product Offerings
Table 80. CSPC HGH Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. CSPC Key News & Latest Developments
Table 82. Novartis Company Summary
Table 83. Novartis HGH Biosimilars Product Offerings
Table 84. Novartis HGH Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Novartis Key News & Latest Developments
Table 86. Kingond Pharm Company Summary
Table 87. Kingond Pharm HGH Biosimilars Product Offerings
Table 88. Kingond Pharm HGH Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Kingond Pharm Key News & Latest Developments
Table 90. HGH Biosimilars Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 91. Global HGH Biosimilars Capacity Market Share of Key Manufacturers, 2021-2023
Table 92. Global HGH Biosimilars Production by Region, 2018-2023 (K Units)
Table 93. Global HGH Biosimilars Production by Region, 2024-2029 (K Units)
Table 94. HGH Biosimilars Market Opportunities & Trends in Global Market
Table 95. HGH Biosimilars Market Drivers in Global Market
Table 96. HGH Biosimilars Market Restraints in Global Market
Table 97. HGH Biosimilars Raw Materials
Table 98. HGH Biosimilars Raw Materials Suppliers in Global Market
Table 99. Typical HGH Biosimilars Downstream
Table 100. HGH Biosimilars Downstream Clients in Global Market
Table 101. HGH Biosimilars Distributors and Sales Agents in Global Market
List of Figures
Figure 1. HGH Biosimilars Segment by Type in 2022
Figure 2. HGH Biosimilars Segment by Application in 2022
Figure 3. Global HGH Biosimilars Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global HGH Biosimilars Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global HGH Biosimilars Revenue, 2018-2029 (US$, Mn)
Figure 7. HGH Biosimilars Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by HGH Biosimilars Revenue in 2022
Figure 9. By Type - Global HGH Biosimilars Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global HGH Biosimilars Revenue Market Share, 2018-2029
Figure 11. By Type - Global HGH Biosimilars Sales Market Share, 2018-2029
Figure 12. By Type - Global HGH Biosimilars Price (USD/Unit), 2018-2029
Figure 13. By Application - Global HGH Biosimilars Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global HGH Biosimilars Revenue Market Share, 2018-2029
Figure 15. By Application - Global HGH Biosimilars Sales Market Share, 2018-2029
Figure 16. By Application - Global HGH Biosimilars Price (USD/Unit), 2018-2029
Figure 17. By Region - Global HGH Biosimilars Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global HGH Biosimilars Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global HGH Biosimilars Revenue Market Share, 2018-2029
Figure 20. By Region - Global HGH Biosimilars Sales Market Share, 2018-2029
Figure 21. By Country - North America HGH Biosimilars Revenue Market Share, 2018-2029
Figure 22. By Country - North America HGH Biosimilars Sales Market Share, 2018-2029
Figure 23. US HGH Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 24. Canada HGH Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico HGH Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe HGH Biosimilars Revenue Market Share, 2018-2029
Figure 27. By Country - Europe HGH Biosimilars Sales Market Share, 2018-2029
Figure 28. Germany HGH Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 29. France HGH Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. HGH Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 31. Italy HGH Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 32. Russia HGH Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries HGH Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux HGH Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia HGH Biosimilars Revenue Market Share, 2018-2029
Figure 36. By Region - Asia HGH Biosimilars Sales Market Share, 2018-2029
Figure 37. China HGH Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 38. Japan HGH Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea HGH Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia HGH Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 41. India HGH Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America HGH Biosimilars Revenue Market Share, 2018-2029
Figure 43. By Country - South America HGH Biosimilars Sales Market Share, 2018-2029
Figure 44. Brazil HGH Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina HGH Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa HGH Biosimilars Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa HGH Biosimilars Sales Market Share, 2018-2029
Figure 48. Turkey HGH Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 49. Israel HGH Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia HGH Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 51. UAE HGH Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 52. Global HGH Biosimilars Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production HGH Biosimilars by Region, 2022 VS 2029
Figure 54. HGH Biosimilars Industry Value Chain
Figure 55. Marketing Channels
